NISA INVESTMENT ADVISORS, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$75,043
+111904.5%
736
-0.7%
0.00%0.0%
Q1 2023$67
+570.0%
741
+195.2%
0.00%
Q4 2022$10
-99.9%
251
+2.4%
0.00%
Q3 2022$8,000
-11.1%
245
-21.0%
0.00%
Q2 2022$9,000
-98.4%
310
-98.2%
0.00%
-100.0%
Q1 2022$570,000
+10.9%
17,389
-4.9%
0.00%0.0%
Q4 2021$514,000
+192.0%
18,278
+945.1%
0.00%
+300.0%
Q3 2021$176,000
-50.0%
1,749
-29.7%
0.00%
-50.0%
Q2 2021$352,000
+21.0%
2,488
-14.7%
0.00%0.0%
Q1 2021$291,000
+37.3%
2,918
+69.8%
0.00%
+100.0%
Q4 2020$212,000
+100.0%
1,718
+58.6%
0.00%0.0%
Q3 2020$106,000
-69.7%
1,083
-51.7%
0.00%
-66.7%
Q2 2020$350,000
+136.5%
2,242
+119.2%
0.00%
+50.0%
Q1 2020$148,000
-27.8%
1,023
+2.0%
0.00%0.0%
Q4 2019$205,000
+78.3%
1,003
-29.9%
0.00%
+100.0%
Q3 2019$115,000
+721.4%
1,430
+853.3%
0.00%
Q2 2019$14,000
+7.7%
1500.0%0.00%
Q1 2019$13,0001500.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders